Paragon Financial Partners, Inc. Merck & Co., Inc. Transaction History
Paragon Financial Partners, Inc.
- $127 Million
- Q1 2025
A detailed history of Paragon Financial Partners, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Paragon Financial Partners, Inc. holds 3,080 shares of MRK stock, worth $246,892. This represents 0.22% of its overall portfolio holdings.
Number of Shares
3,080
Previous 3,483
11.57%
Holding current value
$246,892
Previous $346,000
20.23%
% of portfolio
0.22%
Previous 0.26%
Shares
14 transactions
Others Institutions Holding MRK
# of Institutions
3,895Shares Held
1.93BCall Options Held
26.2MPut Options Held
23.5M-
Vanguard Group Inc Valley Forge, PA253MShares$20.2 Billion0.42% of portfolio
-
Black Rock Inc. New York, NY207MShares$16.6 Billion0.59% of portfolio
-
State Street Corp Boston, MA121MShares$9.66 Billion0.46% of portfolio
-
Wellington Management Group LLP Boston, MA81.7MShares$6.55 Billion1.46% of portfolio
-
Geode Capital Management, LLC Boston, MA59.7MShares$4.78 Billion0.43% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $203B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...